DNB Asset Management AS Has $44.89 Million Holdings in Bath & Body Works, Inc. $BBWI

DNB Asset Management AS raised its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 35.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,498,255 shares of the company’s stock after acquiring an additional 394,464 shares during the period. DNB Asset Management AS owned approximately 0.71% of Bath & Body Works worth $44,888,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in BBWI. Stonehage Fleming Financial Services Holdings Ltd bought a new stake in Bath & Body Works in the 2nd quarter valued at $33,000. SVB Wealth LLC acquired a new stake in shares of Bath & Body Works during the first quarter worth $35,000. Geneos Wealth Management Inc. boosted its position in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC grew its stake in shares of Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after acquiring an additional 481 shares in the last quarter. Finally, Parkside Financial Bank & Trust grew its stake in shares of Bath & Body Works by 24.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after acquiring an additional 364 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Down 24.7%

NYSE BBWI opened at $15.83 on Friday. The company has a market cap of $3.26 billion, a price-to-earnings ratio of 4.70, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a twelve month low of $15.43 and a twelve month high of $41.87. The business’s fifty day moving average is $24.83 and its 200 day moving average is $28.25.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the company earned $0.49 EPS. Bath & Body Works’s revenue for the quarter was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. On average, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Friday, November 21st will be given a dividend of $0.20 per share. The ex-dividend date is Friday, November 21st. This represents a $0.80 annualized dividend and a yield of 5.1%. Bath & Body Works’s dividend payout ratio (DPR) is currently 23.74%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. UBS Group dropped their price objective on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a research note on Friday, August 29th. The Goldman Sachs Group cut Bath & Body Works from a “buy” rating to a “neutral” rating and set a $17.00 price target for the company. in a research note on Thursday. Jefferies Financial Group reduced their price target on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research report on Monday, October 13th. Citigroup dropped their price objective on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating for the company in a report on Tuesday, August 19th. Finally, Wall Street Zen downgraded Bath & Body Works from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Ten equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $34.17.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.